Front Row Advisors LLC Spdr Ser Tr Spdr S&P Pharmaceu Transaction History

Front Row Advisors LLC

  • $271 Million
  • Q3 2024

A detailed history of Front Row Advisors LLC transactions in Spdr Ser Tr Spdr S&P Pharmaceu stock. As of the latest transaction made, Front Row Advisors LLC holds 45 shares of XPH stock, worth $2,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 45 -0.0%
Holding current value
$2,046
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 22, 2023
BUY
$39.61 - $44.25 $1,703 - $1,902
43 Added 2150.0%
45 $2,000
Q1 2023

May 15, 2023
BUY
$39.61 - $44.25 $79 - $88
2 New
2 $5,000
Q4 2022

Feb 15, 2023
SELL
$40.06 - $43.59 $1,802 - $1,961
-45 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$41.55 - $46.61 $41 - $46
1 Added 2.27%
45 $0
Q1 2019

May 17, 2019
BUY
N/A
44 New
44 $2,000

Others Institutions Holding XPH

# of Institutions
78
Shares Held
2.4M
Call Options Held
18.8K
Put Options Held
30.5K
View Full List

About SPDR SER TR SPDR S&P PHARMACEU

XPH Quotes by TradingView
  • Ticker XPH
  • Sector ETFs
  • Industry ETFs
More about XPH
Track This Portfolio

Track Front Row Advisors LLC Portfolio

Follow Front Row Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Row Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email